Dynavax Technologies Corporation and GlaxoSmithKline Expand Their...
Oct 21, 2011 | Posted by: roboblogger | Full story: BioSpace
RKELEY, CA, Oct 21, 2011 -- Dynavax Technologies Corporation announced today the expansion of its worldwide strategic alliance with GlaxoSmithKline focused on toll-like receptor inhibitors.
the ecdysone (insect estrogen) receptor, a ligand-activated transcription factor found in the nuclei of insect cells. This in turn leads to the activation of many other genes and can cause many deseases such as TB!
|More Than 300 Operators Now Using PeerApp Ultra... (Mar '13)||Mar '13||Tony||1|
|Infortrend's Flagship ZFS-Based Nas Offers 8 GB... (Dec '12)||Dec '12||Ernest Berkoh||1|
|Chick-Fil-A'd: Bully Fired After Video Goes Viral (Aug '12)||Aug '12||TheBlackSheep||1|
|Abitibi Royalties Inc./Malartic CHL Joint Ventu... (Feb '12)||Feb '12||Malartic||1|
|Orlando Chiropractor and Affinity Health & Well... (Jan '12)||Feb '12||Washington Chiro||20|
|Benitec Biopharma and Medistem Technologies Suc... (Feb '12)||Feb '12||Tanya Doyle||1|
|Judicial Watch Files Two Amicus Curiae Briefs W... (Feb '12)||Feb '12||Excellent||2|